Search Results
Slidesets
(Abstract) Next generation sequencing in routine HIV-1 resistance diagnostic - frequency of additional resistance relevant mutations in 2% and 1% population | Dr. R. Ehret
Presented at:
European Meeting on HIV & Hepatitis 2016
Slidesets
Optimal use of INSTI’s in routine practice | Carlos Brites, MD, PhD
Presented at:
Rio de Janeiro HIV Clinical Forum 2018
Slidesets
Other Viruses: using Wolbachia to interrupt transmission of viral infections such as Dengue, Chikungunya and Zika - Steven Kern, PhD
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Slidesets
Update on COVID-19 Therapeutics (September 2022 Edition) - D. Kuritzkes, MD
Presented at:
COVID-19 Clinical Forum 2022
Slidesets
Challenges in Caring for HIV-TB Coinfected Patients - Grace Chung-Yan Lui, MBChB (Hons), FHKCP, FHKAM
Presented at:
Asia-Pacific HIV Clinical Forum 2019
Slidesets
Optimal use of integrase inhibitors in routine clinical practice | Anton Pozniak, MD, FRCP
Presented at:
Russian HIV Clinical Forum 2018
Abstracts
Emergence of Resistance in HIV-1 Integrase following Dolutegravir Treatment in Participants Aged 4 Weeks to <18 Years: Results from the IMPAACT P1093 Study
C. Vavro
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Slidesets
Oral Abstract Presentation #21 | Collins Ambe Chenwi
Presented at:
European Meeting on HIV & Hepatitis 2024